Stay updated on Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page now displays a 403 Forbidden error, with the header and footer present but the study content not shown. This indicates an access/server issue rather than a substantive update to the page content.SummaryDifference18%

- Check41 days agoChange DetectedThe page now shows revision v3.6.6 instead of v3.6.5, representing a new site build. This appears to be a maintenance or UI deployment rather than a change to study data or content.SummaryDifference0.1%

- Check62 days agoChange DetectedThe study record page now shows a server error page, replacing the detailed trial information with a generic error message; the page no longer displays the study's metadata and locations.SummaryDifference17%

- Check77 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a minor update to the study record display on ClinicalTrials.gov.SummaryDifference0.1%

- Check98 days agoChange DetectedThe revision label on the page was updated from v3.6.2 to v3.6.3, indicating a new version of the page content. This appears to be a minor update without changes to the study details.SummaryDifference0.1%

- Check105 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a minor update to the page metadata.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page.